<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	
	>
<channel>
	<title>
	Commenti a: Edgewise Therapeutics annuncia i risultati intermedi positivi a quattro mesi dello studio in aperto ARCH con EDG-5506 negli adulti con distrofia muscolare di Becker (BMD)	</title>
	<atom:link href="https://www.parentproject.it/2022/09/16/edgewise-therapeutics-annuncia-i-risultati-intermedi-positivi-a-quattro-mesi-dello-studio-in-aperto-arch-con-edg-5506-negli-adulti-con-distrofia-muscolare-di-becker-bmd/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.parentproject.it/2022/09/16/edgewise-therapeutics-annuncia-i-risultati-intermedi-positivi-a-quattro-mesi-dello-studio-in-aperto-arch-con-edg-5506-negli-adulti-con-distrofia-muscolare-di-becker-bmd/</link>
	<description>Insieme per fermare la Duchenne e la Becker</description>
	<lastBuildDate>Fri, 16 Sep 2022 07:47:29 +0000</lastBuildDate>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>
</channel>
</rss>
